Pagenax

Pagenax Description

brolucizumab

Manufacturer:

Novartis Indonesia
Full Prescribing Info
Description
Sterile, clear to slightly opalescent, colorless to slightly brownish-yellow and preservative-free aqueous solution.
Brolucizumab is a humanized monoclonal single-chain Fv (scFv) antibody fragment with a molecular weight of ~26 kDa, produced in Escherichia coli cells by recombinant DNA technology.
One mL solution for injection contains 120 mg of brolucizumab.
Each vial contains 27.6 mg of brolucizumab in 0.23 mL solution. This provides a usable amount to deliver a single dose of 0.05 mL containing 6 mg of brolucizumab.
Excipients/Inactive Ingredients: 10 mM sodium citrate, 5.8% sucrose, 0.02% polysorbate 80 and water for injection and has a pH of approximately 7.2.
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan